Neon Therapeutics

Identifying patient-derived, tumor-specific neoantigens for the development of individualized and off-the-shelf cancer vaccines.

placeCambridge, Massachusetts, United States calendar_todayFounded 2015 groups306 employees language neontherapeutics.com

Registered entities

Innovation

16 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 1,127 times.

YearFilings
20171
20184
20198
202010
20215
20232

Investor mix

13 investors on record; lead investors include Access Industries, PFM Health Sciences, Clal Biotechnology Industries, Third Rock Ventures; 3 have since exited.

Investor typeCountShare
Venture capital646%
Private equity323%
Other / undisclosed431%
Coming soon